Medical Journal March 11, 2023

Published Date: 17 Mar 2023

Today's top news includes: New study finds millions of people around the world are having heart attacks after being tested for COVID-19 vaccines...

Read Full News

Latest News

Look Once, Think Twice: The Art of Neurologic Diagnosis

Many neurologic conditions hide behind subtle signs, and neurophobia can further confound the diagnosis. A neurologists provides tips on when to pause and think again.

Beta-Blocker Use After Myocardial Infarction: When to Stop?

New trial data question routine long term beta blocker use after myocardial infarction in stable patients with preserved function, prompting reassessment of continuation decisions.

Ready or Not, LLMs Are Coming for Medicine

Current chatbots might show deficiencies in clinical reasoning for now, but don’t hold your breath.

SGO 2026

Read clinically focused news coverage of key developments from SGO 2026

Apr 10 2026 This Week in Cardiology

Three imaging-guided PCI trials (two with surprising results), LDL targets, an oral PCSK9 inhibitor, and another beta-blocker withdrawal trial are the topics John Mandrola, MD, discusses in this week’s podcast.

When Binge Eating Becomes an Emergency

A single binge episode may precipitate acute gastric dilatation, a rare but life-threatening condition that clinicians can easily miss.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Latest News

Many neurologic conditions hide behind subtle signs, and neurophobia can further confound the diagnosis. A neurologists provides tips on when to pause and think again.

New trial data question routine long term beta blocker use after myocardial infarction in stable patients with preserved function, prompting reassessment of continuation decisions.

Current chatbots might show deficiencies in clinical reasoning for now, but don’t hold your breath.

Read clinically focused news coverage of key developments from SGO 2026

Three imaging-guided PCI trials (two with surprising results), LDL targets, an oral PCSK9 inhibitor, and another beta-blocker withdrawal trial are the topics John Mandrola, MD, discusses in this week’s podcast.

A single binge episode may precipitate acute gastric dilatation, a rare but life-threatening condition that clinicians can easily miss.

News All Time

Bannwarth Syndrome in a Woman With Early Breast Cancer

The case emphasizes Bannwarth syndrome as a rare but treatable cause of neurologic deterioration in an older woman receiving surgical cancer care.

Can Large Language Models Simplify Radiology Reports?

A meta-analysis suggests that large language model-simplified radiology reports improve patient understanding and readability while preserving high accuracy and completeness.

NPH: What You Learned in Med School Is Wrong

Neurologists Indu Subramanian and Alfonso Fasano discuss normal pressure hydrocephalus and why some of the classic dogma about this condition is wrong.

Promoting Whole-Body Imaging: Not There Yet

Ethicist Art Caplan discusses marketing promotions for expensive whole-body imaging.

Medicine Will Turn Cellular Age Backward by 2050: Barzilai

Aging may not be permanent. Nir Barzilai explains how human cells reset to zero and why partial rejuvenation could be possible within decades.

Adding to the Toolbox: Thyroid Artery Embolization

Drs Kaniksha Desai and Juan Camacho discuss thyroid artery embolization.

The Time Burden of Cancer Treatment

Dr Kathy Miller discusses a recent study quantifying the hidden time burden of cancer care and its impact on clinic operations and patient experience.

ASCO GI: Updates in Pancreatic, Gastric, CRC

Dr Emil Lou highlights practice-changing updates from ASCO GI, including new immunotherapy, targeted therapy, and circulating tumor DNA advances across gastrointestinal cancers.

High-speed imaging tracks live brain cell activity in awake mice

A research team from the School of Engineering at The Hong Kong University of Science and Technology (HKUST) has achieved a breakthrough in brain imaging by developing the world's first technology to capture high-resolution ...

Study highlights AI limits in heart care

There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at Cedars-Sinai published in the Journal of the American Society of Echocardiography.

New material may outperform current agents used in medical imaging

Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic to patients and more environmentally ...

Imaging technique maps the brain's nerve fiber labyrinth with micrometer precision

In order to understand brain diseases, neuroscientists try to untangle the intricate nerve fiber labyrinth of our brain. Before analyzing brain tissue under a microscope, it is often soaked in paraffin wax to achieve high-quality ...

New brain atlas offers unprecedented detail in MRI scans

A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging.

Holographic optogenetics could enable faster brain mapping for new discoveries

Recent technological advances have opened new possibilities for neuroscience research, allowing researchers to map the brain's structure and synaptic connectivity (i.e., the junctions via which neurons communicate with each ...

New method noninvasively measures Achilles tendon structure and function in professional dancers

A study in the Journal of Orthopaedic Research uses a noninvasive, nonradioactive imaging-based method to measure the structure and function of the Achilles tendon in professional ballet dancers. The method could potentially ...

MRI-based evaluation system accurately quantifies paraspinal muscle atrophy and nerve root injury severity

A noninvasive MRI technique that measures volumetric changes in paraspinal muscles could transform how doctors assess nerve damage in the cervical spine, which helps guide more precise treatment decisions and potentially ...

Recommended News For You

Early palliative care billing up from 2010 to 2019 for advanced cancer

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

Prostate Cancer Treatment Associated With Long-Term Complications

Childhood cancer survivors face new health problems later in life, study shows

Australian researchers attribute drop in melanoma rates to increasingly diverse population

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

Recommended Articles For You

Symptoms and Causes of Phlegmasia Cerulea Dolens: A Comprehensive Guide  

Hope for a Cure: Exploring New Treatments for Sickle Cell Anemia 

Cancer Vaccines In India: The Latest Hope In The Fight Against Disease 

The Miracle of Thyrogen Injection: A New Hope for Thyroid Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer

2.

A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.

3.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

4.

Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer

5.

Underprescribed for Alcohol Use Disorder is pharmacotherapy.

1.

Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA

2.

Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers

3.

Hope in Numbers: Understanding AML Leukemia Survival Rates and Emerging Therapies

4.

Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care

5.

Unveiling the Mysteries of Smudge Cells: A New Frontier in Cellular Biology

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

5.

Navigating the Complexities of Ph Negative ALL - Part IX

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot